Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Welte, M. Miravitlles, N. Karlsson, S. Peterson, G. S. Eriksson, R. Kessler, P. Hernandez, M. R. Partridge (Germany; Barcelona, Spain; Mölndal, Lund, Sweden; Strasbourg, France; Halifax, Canada; London, United Kingdom). Improving morning activities in COPD patients with budesonide/formoterol: Assessment of data from two randomised trials using minimal important differences from a morning activities questionnaire. Eur Respir J 2010; 36: Suppl. 54, 1202

Member's Comments

No comment yet.

Related content which might interest you: Health status changes in COPD patients after real-life switch from tiotropium or salmeterol/fluticasone to indacaterol/glycopyrronium using the EQ-5D-3L instrument: results from the POWER study Source: International Congress 2018 – COPD management Year: 2018 Combined tiotropium + olodaterol influences physical functioning in COPD: Results of an open-label observational study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Patient-reported outcomes (PROs) and reliever use in Japanese and European patients with chronic obstructive pulmonary disease receiving formoterol 4.5 and 9μg twice daily: Results of the OCEAN phase III study Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 QVA149 administered once daily provides significant improvements in lung function over 1 year in patients with COPD: The ENLIGHTEN study Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 Comparison of the administration of COPD assessment test by face-to-face interview versus telephone interview: A randomized trial Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Late Breaking Abstract - A randomized clinical study to assess the impact of budesonide/formoterol (BUD/FM) pMDI medication reminders on adherence in COPD patients Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 Impact of different intensities of resistance training on health status focusing on activities of daily living in patients with COPD: randomized controlled study Source: International Congress 2019 – Insights into rehabilitation and physical activity of patients with respiratory disease Year: 2019 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Characterization of exercise impairment in relation to quality of life (QoL) and hospital admission in COPD patients; data from the INTERCOM trial Source: Eur Respir J 2005; 26: Suppl. 49, 433s Year: 2005 Differences in proxy-reported and patient-reported outcomes: Assessing problematic activities of daily life in patients with COPD Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences Year: 2016 Are there patient characteristics associated with improvements or worsening in the placebo arm of COPD tlinical trials? Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Gender differences in health status in patients with COPD: baseline characteristics of a multi-centre intervention and characterisation study on Seretide (COSMIC) Source: Eur Respir J 2002; 20: Suppl. 38, 262s Year: 2002 Budesonide/formoterol adjustable maintenance dosing effectively improves asthma symptom severity: a multicentre Canadian study Source: Eur Respir J 2003; 22: Suppl. 45, 258s Year: 2003 Examination of variations in responder rates in COPD clinical trial outcomes Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Quality of life of patients with stable COPD receiving outpatient care of a respiratory nurse: a randomised controlled trial Source: Annual Congress 2003 - Education for asthma patients and different aspects concerning COPD Year: 2003 A prospective observational study of the impact of COPD on daily life following the initiation of indacaterol Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial Source: Eur Respir J, 52 (4) 1800063; 10.1183/13993003.00063-2018 Year: 2018 Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial Source: International Congress 2019 – Therapeutic breakthrough Year in review Year: 2019